This is part of the continuum of my focus on oligometastatic cancers. I won't delve into "controversies" around metastatic prostate, but it calls into question- whether the sole basis of partin's nomograms around nodal involvement has been understaged and pelvic dissection of nodes incomplete. Numerous contemporary studies fail to account for these two basic statements. … Continue reading What is the optimal strategy for oligometastatic prostatic cancers? →